Interim results from Phase 3 clinical trials revealed that two vaccine candidates—one from the Pfizer and BioNTech and another from ... they are both made with messenger RNA (mRNA). mRNA vaccines work ...

Pfizer executives opened their doors virtually to USA TODAY to walk through the painstaking and time-consuming process of making a messenger RNA, or mRNA vaccine. It starts with circular snippets ...

Vaccines using messenger RNA ... Vaccines using mRNA are based on RNA technology that dates back to the 1960s. In response to ...

While the reason behind the poorer quality of vaccines sent to the EU is unclear, Pfizer's jab is made from extremely volatile genetic material known as messenger RNA (mRNA), which at the time ...

The European Patent Office declared a patent owned by CureVac , valid, after a challenge from drugmaker BioNTech , the company said on Thursday.

BioNTech SE is internationally recognized for its advancements in messenger RNA (mRNA) technology particularly ... Its partnerships, notably with Pfizer (among others), underscore its capacity ...

Novavax's traditional protein-based COVID shot offers an alternative technology to messenger RNA-based rivals from Pfizer-BioNTech and Moderna, but has failed to make a mark in the U.S. vaccine ...

In a related development also Wednesday ... Meanwhile, Europe's sanitary regulating agency EMA Thursday approved Pfizer's messenger RNA (ribonucleic acid) vaccine for children aged 5 to 11.

In a legal battle between BioNTech and CureVac, the European Patent Office declared a patent owned by CureVac ...